Delmonico Lucas, Costa Maurício Augusto Silva Magalhães, Azevedo Carolina Maria de, Silvestre Rafaele Tavares, Scherrer Luciano Rios, Ornellas Maria Helena Faria, Alves Gilda
Circulating Biomarkers Laboratory, Faculty of Medical Sciences, Rio de Janeiro State University, Rio de Janeiro, Brazil.
Medical Sciences Graduation Program (PGCM), Faculty of Medical Sciences, Rio de Janeiro State University, Rio de Janeiro, Brazil. Email:
Asian Pac J Cancer Prev. 2018 Nov 29;19(11):3087-3092. doi: 10.31557/APJCP.2018.19.11.3087.
Background: Low levels of vitamin D have been described as a risk factor for the development of breast cancer. The aim of this study was to evaluate the serum levels of vitamin D (25OHD) in patients with impalpable breast lesions comparing with a control group. Methods: Vitamin D quantification (25OHD) was assessed in the plasma of 65 patients with impalpable breast lesions and from 20 health controls using a chemiluminescent microparticle immunoassay. Pearson’s chi-square test and nonparametric t-Student were used to evaluate statistical significance between the clinical variables and the means of quantification of vitamin D. The receiver operating characteristic (ROC) curve was used to evaluate the correlation between age and vitamin sufficiency for the cases and the controls. Results: The prevalence of vitamin D deficiency and/or insufficiency in women with malignant lesions was 84% and 60% for the control group. Using the chi-square or Fisher’s exact test, the relationship between vitamin D levels and age presented significant association only for the control group (P=0.002). Using ROC curve, the plot area (0.778) for the control group defined a cut-off value of 45 years to age, with specificity and sensitivity of 60% and 50%, respectively. Thus, the odds ratio for vitamin D insufficiency in women over 45 years was 1.37 (P=0.011). For the case group, clinical characteristics, histological grade, and lymph node involvement did not show any significant association. Conclusion: The prevalence of vitamin D deficiency/insufficiency is high in women with impalpable breast lesions, as well as in the control group, even in a tropical city. According to the results the age advancement may be involved with the decrease in vitamin D levels in plasma, but there was no statistical association between low levels of Vitamin D and breast cancer.
低水平的维生素D被认为是乳腺癌发生的一个风险因素。本研究的目的是评估不可触及乳腺病变患者的血清维生素D(25羟维生素D)水平,并与对照组进行比较。方法:采用化学发光微粒子免疫分析法,对65例不可触及乳腺病变患者和20名健康对照者的血浆进行维生素D定量(25羟维生素D)检测。采用Pearson卡方检验和非参数t检验评估临床变量与维生素D定量均值之间的统计学意义。采用受试者工作特征(ROC)曲线评估病例组和对照组年龄与维生素充足之间的相关性。结果:恶性病变女性患者维生素D缺乏和/或不足的患病率为84%,对照组为60%。使用卡方检验或Fisher精确检验,维生素D水平与年龄之间的关系仅在对照组中呈现显著相关性(P = 0.002)。使用ROC曲线,对照组的曲线下面积(0.778)确定年龄的截断值为45岁,特异性和敏感性分别为60%和50%。因此,45岁以上女性维生素D不足的比值比为1.37(P = 0.011)。对于病例组,临床特征、组织学分级和淋巴结受累情况均未显示出任何显著相关性。结论:即使在热带城市,不可触及乳腺病变女性患者以及对照组中维生素D缺乏/不足的患病率都很高。根据研究结果,年龄增长可能与血浆中维生素D水平降低有关,但维生素D水平低与乳腺癌之间没有统计学关联。